TheStreet reissued their buy rating on shares of Merck & Co., Inc. (NYSE:MRK) in a research note released on Tuesday morning, AnalystRatings.Net reports. Merck & Co., Inc. (NYSE:MRK) stock opened at $51.21 in current trading session, and trading at $51.22, trading in the range of $50.86 – $51.49. The stock showed a negative weekly performance of -3.11%.
Pfizer Inc. (NYSE:PFE) announced top-line results from a Phase 3 study of investigational agent ALO-02 in patients with moderate-to-severe chronic low back pain. In this study, ALO-02 met the primary efficacy endpoint, demonstrating a statistically significant difference from placebo. This was a 12-week, double-blind, placebo-controlled, randomized withdrawal design efficacy and safety study in patients with moderate-to-severe chronic low back pain. Pfizer Inc. (NYSE:PFE) stock decreased -0.67% and trading at $31.06. The EPS of the stock remained 1.45. Company’s market capitalization is $201.56 billion.
Bristol-Myers Squibb Co (NYSE:BMY)had its price objective hosited by Argus from $58.00 to $62.00 in a report released on Wednesday, AnalystRatings.NET reports. Argus currently has a buy rating on the stock. Bristol-Myers Squibb Co (NYSE:BMY) stock opened at $54.31 in current trading session and trading at $53.33. The 52 week range of the stock is $34.61 – $56.83 and the day range was $52.71 – $54.31.
Celsion Corporation (NASDAQ:CLSN), announced that the company is formalizing a program to pursue the development of ThermoDox® to investigate applications for treating brain cancer tumors, notably Glioblastoma Multiforme or GBM. In addition to jointly submitting multiple grant applications, the company is also pursuing preclinical studies in collaboration with Dr. Costas D. Arvanitis at the Brigham and Women’s Hospital and Harvard Medical School. Experiments will study the use of ThermoDox in combination with MR guided High Intensity Focused Ultrasound (HIFU) to treat brain tumors, initially in animal models. Celsion Corporation (NASDAQ:CLSN) shares trading at $3.78 on current trade day, by decreasing -1.82%. Stock 52 week range is $3.38 – $38.03. Company’s market capitalization is $11.52 billion.